These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6098977)

  • 1. Studies on osteoporosis X. Effect of estrogen-progestin combination on heparin-induced osteoporosis.
    Robin JC; Ambrus JL; Ambrus CM
    Steroids; 1983 Dec; 42(6):669-75. PubMed ID: 6098977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on osteoporoses. VIII. Effect of estrogen on steroid induced osteoporosis.
    Robin JC; Ambrus JL
    J Med; 1982; 13(5-6):453-63. PubMed ID: 6302190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on osteoporosis. II. Effect of estrogens and fluoride on experimental osteoporosis. A preliminary report.
    Robin JC; Schepart B; Calkins H; LoSasso G; Thomas CC; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1979 Mar; 23(3):647-50. PubMed ID: 223209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on osteoporosis III. Effect of estrogens and fluoride.
    Robin JC; Schepart B; Calkins H; LoSasso G; Thomas CC; Ambrus JL
    J Med; 1980; 11(1):1-14. PubMed ID: 6249879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on osteoporoses. XII. Effect of imidazoquinazolinones on experimental osteoporosis. A preliminary report.
    Robin JC; Ambrus JL
    J Med; 1982; 13(5-6):465-72. PubMed ID: 6963333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis.
    Robin JC; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):491-8. PubMed ID: 7079575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the pathophysiology and therapy of osteoporosis.
    Ambrus JL; Ambrus JL; Robin JC; Ambrus CM; Kahn EA
    J Med; 1984; 15(4):295-309. PubMed ID: 6396359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium.
    Ettinger B; Genant HK; Cann CE
    Ann Intern Med; 1987 Jan; 106(1):40-5. PubMed ID: 3789576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on osteoporosis VII. Effect of 17 beta-hydroxy-4-estren-3-one 17-decanoate on experimental osteoporosis.
    Robin JC; Suh OW; Ambrus JL
    Steroids; 1982 Aug; 40(2):125-32. PubMed ID: 7157449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on osteoporosis. IX. Effect of fluoride on steroid induced osteoporosis.
    Robin JC; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):453-61. PubMed ID: 7178655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A
    J Reprod Med; 1993 Dec; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.
    Heald A; Selby PL; White A; Gibson JM
    Am J Obstet Gynecol; 2000 Sep; 183(3):593-600. PubMed ID: 10992179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on osteoporoses. XI. Effects of a methylxanthine derivative. A preliminary report.
    Robin JC; Ambrus JL
    J Med; 1983; 14(2):137-45. PubMed ID: 6310016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of progestins.
    Mishell DR
    Postgrad Med; 1989 Apr; Spec No():84-8; discussion 89-90. PubMed ID: 2542913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone protection for early menopausal women in China: standard or half-dose estrogen with progestin? A one-year prospective randomized trail.
    Zhu SY; Deng Y; Wang YF; Xue W; Ma X; Sun A
    Gynecol Endocrinol; 2019 Feb; 35(2):165-169. PubMed ID: 30449208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen plus a progestin for prevention of postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1985 Oct; 27(699):91-2. PubMed ID: 3903458
    [No Abstract]   [Full Text] [Related]  

  • 20. Progestins and estrogens and Alzheimer's disease.
    Honjo H; Iwasa K; Kawata M; Fushiki S; Hosoda T; Tatsumi H; Oida N; Mihara M; Hirasugi Y; Yamamoto H; Kikuchi N; Kitawaki J
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):305-8. PubMed ID: 15860274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.